Showing results (731-740 of 10,067) with videos related to
Sort By:
Pageof 1,007
Current Pharmaceutical Design|June 24, 2017
Method Development in Forensic ToxicologyFrank T Peters, Dirk K Wissenbach, Francesco Paolo Busardo, et al.Current Pharmaceutical Design|June 24, 2017
Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and CancerJens Oellgaard, Signe Abitz Winther, Tobias Schmidt Hansen, et al.Current Pharmaceutical Design|June 24, 2017
Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral SclerosisMariana Pehar, Benjamin A Harlan, Kelby M Killoy, et al.Current Pharmaceutical Design|June 24, 2017
Overview of Forensic Toxicology, Yesterday, Today and in the FutureHeesun Chung, Sanggil ChoeCurrent Pharmaceutical Design|June 24, 2017
LSD Detection and Interpretation in HairCamille Richeval, Delphine Allorge, Xavier Vanhoye, et al.Current Pharmaceutical Design|June 24, 2017
Metallothionein is a Potential Therapeutic Strategy for Amyotrophic Lateral SclerosisShin-Ichi OnoCurrent Pharmaceutical Design|June 24, 2017
Functional Nanoparticles and their Interactions with Mesenchymal Stem CellsWeiwei Wang, Zijun Deng, Xun Xu, et al.Current Pharmaceutical Design|June 24, 2017
Role of Bradykinin in the Regulation of Endothelial Nitric Oxide Synthase Expression by Cardiovascular DrugsJin Bo SuCurrent Pharmaceutical Design|November 25, 2005
Interactions of primary amphipathic cell penetrating peptides with model membranes: consequences on the mechanisms of intracellular delivery of therapeuticsSébastien Deshayes, May C Morris, Gilles Divita, et al.Current Pharmaceutical Design|November 25, 2005
Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agentsT S Zatsepin, J J Turner, T S Oretskaya, et al.Pageof 1,007